首页
订购/客服:400-666-5481

KPT-330, (E)-RN

    
≥98%

(E)-3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-N'-(PYRAZIN-2-YL)ACRYLOHYDRAZIDE

源叶(MedMol)
S88393 一键复制产品信息
1421923-86-5
C17H11F6N7O
443.3059592
(E)-Selinexor
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S88393-5mg
≥98%

¥400.00

货期:3-5天 - - - -
S88393-10mg
≥98%

¥700.00

货期:3-5天 - - - -
S88393-25mg
≥98%

¥1100.00

货期:3-5天 - - - -
S88393-100mg
≥98%

¥2200.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: KPT330,(E)- is a CRM1-selective inhibitor of nuclear export. It inhibits protein trafficking from the nucleus and induces cell cycle arrest and apoptosis in mesothelioma cells.
靶点: CRM1
细胞实验: Cell lines are cultured in RPMI 1640 medium, supplemented with 10% fetal bovine serum and penicillin/streptomycin. Cell Titer Glo assay is used to assess cell viability upon treatment with either dimethyl sulfoxide (DMSO) or KPT-330. Cells are plated at a density of 10 000 cells per well in a 96-well plate and incubated with DMSO or increasing concentrations of KPT-330. The cell viability is measured after 72 h exposure to KPT-330 and reported as a percentage of DMSO control cells. Jurkat cells that overexpress BCL2 are generated using MSCV-IRES-GFP retroviral expression system. Jurkat cells infected with BCL2 or control vector viruses are sorted by flow cytometry and the expression of BCL2 confirmed by Western blot analysis using BCL2 antibody.(Only for Reference)
参考文献: 1. Tai YT, et al. Leukemia. 2014, 28(1), 155-165. 2. Etchin J, et al. Br J Haematol. 2013, 161(1), 117-127.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.256 ml 11.279 ml 22.558 ml
5 mM 0.451 ml 2.256 ml 4.512 ml
10 mM 0.226 ml 1.128 ml 2.256 ml
50 mM 0.045 ml 0.226 ml 0.451 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×